MedPath

Effects of Individualized Cognitive Training on Cognition in Heart Failure

Not Applicable
Recruiting
Conditions
Heart Failure
Interventions
Other: Cognitive training
Other: Usual Care
Registration Number
NCT05223426
Lead Sponsor
Louis Bherer
Brief Summary

The SYNAPSE trial is designed to study the effects of an individualized home-based cognitive training program on cognitive functions in heart-failure patients.

Detailed Description

The purpose of the SYNAPSE study is to evaluate the effects of an individualized home-based training program aimed to improve cognitive functions and well-being in heart failure patients. Heart failure is characterized by the inability of the heart to pump blood efficiently through the body. Nearly half of patients with heart failure present with cognitive deficits. Memory and executive functions that allow us to perform complex tasks are mainly affected. These cognitive deficits are linked to an increased risk of hospitalization and mortality, in addition to decreasing patients' well-being and ability to care for themselves. Although rehabilitation programs that include physical activity and counseling help reduce heart and brain health risks, these programs are unpopular. Among the few who enroll, between 24% and 50% drop out before the completion of the program. Offering alternative options such as cognitive training would help to reach this proportion of patients. The literature has shown that cognitive training is effective in preventing or reducing cognitive deficits in older adults with or without cognitive loss. Although still understudied in patients with heart failure, a better understanding of the association between heart failure and changes in cognition would allow better adaptation of patient care to their situations and needs.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Adult aged 50 or older
  • Have access to Internet
  • Have access to a computer or a tablet;
  • Have the ability to perform cognitive training;
  • Have the ability to read, understand and consent to the informed consent form;
  • Have chronic heart failure on tolerated therapy for at least two months;
  • Without limitation of physical activity to severe limitation of physical activity (i.e. NYHA class I, class II, class III OR class IV).
Exclusion Criteria
  • Acute cardiovascular event 1 month before randomization;
  • Cardiovascular procedure scheduled within 3 months;
  • Uncontrolled diabetes or untreated thyroid dysfunction;
  • Current or recent malignancy with a life expectancy of less than 1 year;
  • Neurological disease;
  • Chronic hemodialysis or peritoneal dialysis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Cognitive training followed by usual careCognitive trainingUsual care and cognitive training for 6 weeks, followed by usual care (only) for 6 weeks.
Cognitive training followed by usual careUsual CareUsual care and cognitive training for 6 weeks, followed by usual care (only) for 6 weeks.
Usual care followed by cognitive trainingUsual CareUsual care (only) for 6 weeks, followed by cognitive training and usual care for 6 weeks.
Usual care followed by cognitive trainingCognitive trainingUsual care (only) for 6 weeks, followed by cognitive training and usual care for 6 weeks.
Primary Outcome Measures
NameTimeMethod
Changes in performance on trained computerized cognitive tasksBefore and after the 6 weeks of interventions

Trained version of computerized dual-task, modified stroop and n-back tasks

Accuracy (%)

Changes in performance on transfer computerized cognitive tasksBefore and after the 6 weeks of interventions

Transfer version of computerized dual-task, modified stroop and n-back tasks

Accuracy (%)

Secondary Outcome Measures
NameTimeMethod
Changes in performance on neuropsychological testsBefore and after the 6 weeks of interventions

Remote version of validated neuropsychological test

Executive functions

* Trail making test Part B

* Verbal fluency test

* Digit span test

(z-score change)

Change in quality of lifeBefore and after the 6 weeks of interventions

36-Items Short form health Survey (SF-36) (Score ranges from 0-100, with a higher score indicating more favorable health status.)

Change in self-care behaviorBefore and after the 6 weeks of interventions

European Heart-Failure Self-care Behavior Scale-9 (EHFsB-9) (The minimal score is 9 while the maximal score is 45. The higher the score, the less the patient performs self-care behaviors.)

Change in general cognitive functioningBefore and after the 6 weeks of interventions

Remote version of the Montreal Cognitive Assessment. (0-28 score, with a higher score indicating a better cognitive functioning.)

Trial Locations

Locations (2)

Preventive medicine and physical activity center (centre EPIC), Montreal heart Institute

🇨🇦

Montréal, Quebec, Canada

Centre de recherche du centre Hospitalier de l'Université de Montréal (CRCHUM)

🇨🇦

Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath